Mixed hemodiafiltration reduces erythropoiesis stimulating agents requirement in dialysis patients: a prospective randomized study-Reference-Cited by-同舟云学术

Mixed hemodiafiltration reduces erythropoiesis stimulating agents requirement in dialysis patients: a prospective randomized study

Published:2020-02-08 Issue:5 Volume:33 Page:1037-1048
ISSN:1121-8428
Container-title:Journal of Nephrology
language:en
Short-container-title:J Nephrol

Author:

Pedrini Luciano A.,Comelli Mario,Ruggiero Pio,Feliciani Annalisa,Manfrini Vania,Cozzi Giorgio,Castellano Angelo,Pezzotta Mauro,Gatti Guido,Arazzi Marta,Auriemma Laura,di Benedetto Attilio,Stuard Stefano

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1007/s40620-020-00709-0.pdf

Reference43 articles.

1. Locatelli F, Covic A, Eckardt KU, Wiecek A, Vanholder R, on behalf of the ERA-EDTA ERBP Advisory Board. Anemia management in patients with chronic kidney disease: a position statement by the Anemia Working Group of European. Renal Best Practice (ERBP). Nephrol Dial Transplant 2009; 24: 348–354.

2. McFarlane PA, Pisoni RL, Eichleay MA, Wald R, Port FK, Mendelssohn D (2010) International trends in erythropoietin use and hemoglobin levels in hemodialysis patients. Kidney Int 78(2):215–223

3. MacDougall IC, Cooper AC (2002) Erythropoietin resistance: the role of inflammation and pro-inflammatory cytokines. Nephrol Dial Transpl 17(Suppl 11):39–43

4. Alves MT, Vilaca SS, Carvalho M, Fernandes AP, Dusse LM, Gomes KB (2015) Resistance of dialyzed patients to erythropoietin. Rev Bras Hematol Hemoter 37:190–197

5. Solomon SD, Uno H, Lewis EF, Eckardt KU, Lin J, Burdmann EA et al (2010) Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med 363:1146–1155

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Clinical Benefits of High-Volume Hemodiafiltration: Optimizing the Removal of Medium-Weight Uremic Toxins and Beyond;Toxins;2023-08-29

2. Not baseline but time-dependent erythropoiesis-stimulating agent responsiveness predicts cardiovascular disease in hemodialysis patients receiving epoetin beta pegol: A multicenter prospective PARAMOUNT-HD Study;International Journal of Cardiology;2023-03

3. Clinical Management of Hemodialyzed Patients: From Pharmacological Interventions to Advanced Technologies;Journal of Clinical Medicine;2022-07-25

4. Comparative Effectiveness between Expanded Hemodialysis (Hemodialysis Using a Medium Cut-Off Dialyzer) and Mixed-Dilution Online Hemodiafiltration Using a High-Flux Dialyzer in Removing Middle-Molecule Uremic Toxins;Blood Purification;2022

5. Achieving high convective volume in hemodiafiltration: Lessons learned after successful implementation in the HDFit trial;Hemodialysis International;2020-10-15